China to India: Extract Import Trade Route

The China to India Extract corridor is one of India's established pharmaceutical import routes from China, with 14 shipments documented worth a combined $41.1K USD. The route is dominated by HANGZHOU HUAJIN PHARMACEUTICAL , which alone accounts for roughly 84% of all import value, reflecting the consolidated nature of China's extract export sector.

Across 3 active China suppliers, the average shipment value stands at $2.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with extract's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 21.1%, placing it at rank #18 among India's top extract import origins globally.

On the Indian buyer side, key Indian importers include AMBICA BIO KARE , HERBIFIC PRIVATE LIMITED, TIKISH PHARMACEUTICALS and 1 others. AMBICA BIO KARE is the single largest Indian importer with 2 shipments valued at $34.4K USD.

India's extract imports from China are driven primarily by a handful of large-scale China manufacturers. HANGZHOU HUAJIN PHARMACEUTICAL with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — Indian buyers benefit from China supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — HANGZHOU HUAJIN PHARMACEUTICAL , HENAN STEEDA INDUSTRIAL CO.,LTD, VIVA BIOTECH SHANGHAI — together account for 100% of total trade value on this route. The average shipment value of $2.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as porcine brain extract solution usd and hsi005, rhodiola rosea root extractrosavins 3% min hplc,salidrosides 1% min hplc, batch#20241012 (ayurvedic medecine)hsi005, rhodiola rosea root extractrosavins 3% min hplc,sali, suggesting that Indian buyers tend to consolidate orders across related product lines from the same China supplier.

On the buying side, AMBICA BIO KARE is the largest importer with 2 shipments worth $34.4K USD — representing 84% of all extract imports from China on this route.